Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: John who wrote (2264)	9/2/1998 9:00:00 AM
From: wolfdog2	Read Replies (2) \| Respond to of 4676

I haven't posted on this thread before, but I'm a long time holder of ISIP. I thought I had done really well a few years ago when I sold ISIP after it went through the roof following the Worth article calling it the next MSFT and I later bought it back at ~12. So now I sit with a 40% loss! The thing to keep in mind, as others have pointed out is that the entire biotech sector is down. 50% losses seem to about par for the course. Even though all the companies in the sector are unique, the market treats them as though they were selling fungible goods. So when the biotech sector goes down, they all go down. Just like oil or aluminum stocks. It's this indiscriminate selling on the part of Wall St. that creates bargains. After the huge volume surge yesterday in ISIP, it looks to me as though the stock is putting in a bottom. If I had cash available I'd be a buyer in here.